X-72134530-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001013627.3(NHSL2):​c.586G>A​(p.Glu196Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00495 in 1,165,875 control chromosomes in the GnomAD database, including 262 homozygotes. There are 1,940 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).

Frequency

Genomes: 𝑓 0.0054 ( 30 hom., 204 hem., cov: 25)
Exomes 𝑓: 0.0049 ( 232 hom. 1736 hem. )

Consequence

NHSL2
NM_001013627.3 missense

Scores

2
10

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: 2.45

Publications

1 publications found
Variant links:
Genes affected
NHSL2 (HGNC:33737): (NHS like 2) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015164912).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.126 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSL2NM_001013627.3 linkc.586G>A p.Glu196Lys missense_variant Exon 4 of 8 ENST00000633930.2 NP_001013649.2 Q5HYW2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHSL2ENST00000633930.2 linkc.586G>A p.Glu196Lys missense_variant Exon 4 of 8 5 NM_001013627.3 ENSP00000488668.1 Q5HYW2-1

Frequencies

GnomAD3 genomes
AF:
0.00545
AC:
616
AN:
112996
Hom.:
30
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.000770
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00296
Gnomad ASJ
AF:
0.00677
Gnomad EAS
AF:
0.136
Gnomad SAS
AF:
0.0108
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000375
Gnomad OTH
AF:
0.00393
GnomAD2 exomes
AF:
0.0111
AC:
1245
AN:
112033
AF XY:
0.0105
show subpopulations
Gnomad AFR exome
AF:
0.000316
Gnomad AMR exome
AF:
0.000258
Gnomad ASJ exome
AF:
0.00601
Gnomad EAS exome
AF:
0.137
Gnomad FIN exome
AF:
0.0000862
Gnomad NFE exome
AF:
0.000442
Gnomad OTH exome
AF:
0.00688
GnomAD4 exome
AF:
0.00490
AC:
5156
AN:
1052826
Hom.:
232
Cov.:
29
AF XY:
0.00505
AC XY:
1736
AN XY:
343674
show subpopulations
African (AFR)
AF:
0.000241
AC:
6
AN:
24895
American (AMR)
AF:
0.000287
AC:
8
AN:
27900
Ashkenazi Jewish (ASJ)
AF:
0.00693
AC:
129
AN:
18612
East Asian (EAS)
AF:
0.160
AC:
4328
AN:
27122
South Asian (SAS)
AF:
0.00369
AC:
184
AN:
49835
European-Finnish (FIN)
AF:
0.0000798
AC:
3
AN:
37598
Middle Eastern (MID)
AF:
0.000980
AC:
4
AN:
4083
European-Non Finnish (NFE)
AF:
0.000249
AC:
204
AN:
818444
Other (OTH)
AF:
0.00654
AC:
290
AN:
44337
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
168
336
503
671
839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00543
AC:
614
AN:
113049
Hom.:
30
Cov.:
25
AF XY:
0.00580
AC XY:
204
AN XY:
35199
show subpopulations
African (AFR)
AF:
0.000768
AC:
24
AN:
31239
American (AMR)
AF:
0.00296
AC:
32
AN:
10818
Ashkenazi Jewish (ASJ)
AF:
0.00677
AC:
18
AN:
2659
East Asian (EAS)
AF:
0.136
AC:
485
AN:
3563
South Asian (SAS)
AF:
0.0108
AC:
30
AN:
2768
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6235
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000375
AC:
20
AN:
53321
Other (OTH)
AF:
0.00324
AC:
5
AN:
1545
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00172
Hom.:
16
Bravo
AF:
0.00658
ExAC
AF:
0.00525
AC:
120

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Spinocerebellar ataxia, X-linked Uncertain:1
-
Vavilov Institute of General Genetics RAS, Laboratory of Evolutional Genomics
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T;.
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.81
T;T
MetaRNN
Benign
0.0015
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
2.4
PrimateAI
Benign
0.43
T
Sift4G
Benign
0.10
T;.
Vest4
0.040
ClinPred
0.0072
T
GERP RS
3.4
PromoterAI
0.0091
Neutral
gMVP
0.35

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72630038; hg19: chrX-71354380; COSMIC: COSV108906215; COSMIC: COSV108906215; API